Company intelligence / Profile preview

Novalis Capital Partners

Hampton, New Hampshire, United States

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Novalis Capital Partners, operating primarily under the brand Novalis LifeSciences, is a boutique venture capital and advisory firm focused on the life science industry. Founded by industry veterans, including former Bayer and Thermo Fisher Scientific CEO Marijn Dekkers, the firm specializes in investing in "enabling technologies" such as genomics, synthetic biology, diagnostics, and precision medicine. Novalis provides both strategic capital and deep operational expertise to high-growth companies that are transforming healthcare and agriculture. The firm typically targets early-to-growth stage companies that offer innovative tools and platforms for drug discovery, development, and clinical diagnostics.

Industry: Investors

Beyond the preview

Go deeper on Novalis Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novalis Capital Partners.

Explore the full profile